Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-17

Clinical Trial Update: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated capecitabine and oxaliplatin with radiotherapy in patients with unresectable gastrointestinal cancers, including gastric ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Lund University Hospital | Conditions: Stomach Cancer, Gall Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED